Regulora Prescription App Review (Canada 2026): Can You Even Get It?

What is Regulora, and how does it differ from Nerva?

Regulora is a prescription digital therapeutic developed originally by Metalogic Health (later sold to MetaMe Health, and the asset has changed hands again since). It is a 12-week, app-delivered course of gut-directed hypnotherapy specifically indicated for adults with IBS-D (Irritable Bowel Syndrome with Diarrhea). It received FDA clearance as a software-as-a-medical-device for IBS-D, making it the first and only gut-directed hypnotherapy app with prescription DTx (digital therapeutic) status in the United States.

Nerva, by contrast, is a direct-to-consumer wellness app from Mindset Health, a 6-week course based on the same underlying gut-directed hypnotherapy protocol lineage (the Manchester Protocol developed by Peter Whorwell). Nerva has clinical evidence behind it (notably Peters et al's 2016 RCT showing gut-directed hypnotherapy comparable to the low FODMAP diet for IBS), but it does not hold FDA clearance and does not require a prescription. It is available to anyone with an app store account, including Canadians, for roughly $199 CAD per year.

The practical differences come down to four things. First, regulatory status: Regulora is prescription-only and FDA-cleared, Nerva is over-the-counter wellness. Second, indication: Regulora is specifically indicated for IBS-D, while Nerva targets IBS broadly (IBS-C, IBS-D, IBS-M). Third, length: Regulora is 12 weeks, Nerva is 6 weeks. Fourth, access: Regulora requires a US-licensed prescriber and US-side fulfillment, Nerva is available on the Canadian App Store and Google Play tonight for $199.

What is similar: both use gut-directed hypnotherapy as the active mechanism. Both deliver structured audio sessions with progressive relaxation and visualization targeting the gut-brain axis. Both trace their evidence base to the same body of literature on gut-directed hypnotherapy as a tier-2 IBS intervention (NICE guideline, Rome IV criteria treatment chapter, multiple RCTs since 2016).

If you are an IBS-D patient in the US with insurance that covers prescription digital therapeutics, Regulora is the more validated, longer, more specifically indicated option. If you are anywhere in Canada, the comparison is academic because you cannot actually get Regulora at retail.

Does Regulora actually work? (What FDA clearance means, and what it doesn't)

Regulora's FDA clearance is real and meaningful, but it is widely misunderstood by patients. Here is what FDA clearance for a prescription digital therapeutic actually means, and what it does not mean.

What FDA clearance means. Regulora went through the FDA's regulatory pathway for software-as-a-medical-device, submitted evidence of safety and effectiveness for its specific indication (IBS-D in adults), agreed to post-market surveillance, and operates under prescription-only distribution rules. That is a higher bar than a wellness app, which has no FDA review at all. It is also a higher bar than a dietary supplement, which has essentially no premarket review of any kind. Regulora is the only gut-directed hypnotherapy app that has cleared this bar.

What FDA clearance does not mean. It does not mean Regulora is dramatically more effective than Nerva or a clinician-delivered protocol. The underlying mechanism (gut-directed hypnotherapy) is the same. The clinical evidence base for gut-directed hypnotherapy is well-established across delivery methods (Peters 2016 RCT, NICE guideline, Rome IV). What FDA clearance does is validate that Regulora's specific implementation of that protocol works for its specific indication (IBS-D in adults) at a regulatory-grade level. It is a quality and accountability signal. It is not a magic-effectiveness signal.

What it specifically does not mean for Canadians. FDA clearance is a United States regulatory designation. Health Canada is a separate regulator, has its own pathway for software-as-a-medical-device, and as of 2026 has not issued an equivalent authorization for Regulora. A Canadian patient cannot point to FDA clearance as a Canadian regulatory approval, because it is not one. A Canadian doctor cannot prescribe a US prescription digital therapeutic in the normal Canadian prescription system. A Canadian pharmacy cannot dispense it. The FDA clearance is impressive, but it does not translate across the border.

On real-world effectiveness. Published data on Regulora specifically (as distinct from gut-directed hypnotherapy as a category) is thinner than for Nerva because Regulora has been a prescription product with smaller distribution. Published trial data (Berry et al 2023 RCT, n=362, open-label, Regulora vs digital muscle relaxation) showed clinically meaningful IBS-SSS improvement among study participants and stool-consistency response rates around 45 percent in the Regulora arm, with no statistically significant difference vs the muscle relaxation comparator. The effectiveness signal is in a rough range consistent with the broader gut-directed hypnotherapy literature. Completion rates for prescription digital therapeutics tend to be higher than for direct-to-consumer wellness apps (the Nerva 6-week completion rate is roughly 9% per Peters 2023 real-world data, prescription DTx completion is often higher because there is a prescriber involved). But the underlying treatment is the same family.

If you are evaluating whether to invest the effort of pursuing Regulora across the border, the honest framing is: yes, it works, the FDA validation is real, but the active ingredient (gut-directed hypnotherapy) is available in Canada at retail through Nerva or in person through a credentialed clinician. You are paying for the regulatory validation and the 12-week structure, not for a fundamentally different treatment.

Can Canadian patients actually get Regulora? (The honest answer)

Short answer: not easily, and not at retail. Here is the long answer, with the specific friction points laid out.

No direct Canadian retail. Regulora is not listed in the Canadian App Store or Google Play as a directly purchasable product. There is no Canadian website where you can sign up, enter a credit card, and receive an activation code. Mindset Health's Nerva is on the Canadian app stores, Regulora is not. This is by design, because Regulora is a prescription product and Canadian prescription rules do not currently route to it.

No Health Canada equivalent. Health Canada has a software-as-a-medical-device pathway, but as of 2026 Regulora does not hold a Canadian medical device licence. That means a Canadian physician cannot write a Canadian prescription for it through the normal channels. A Canadian patient cannot bring an FDA clearance to a Canadian pharmacist and expect dispensing. The regulatory recognition simply does not exist on this side of the border.

The cross-border workaround that some patients attempt. It looks like this. You find a US-licensed physician willing to consult and prescribe (telemedicine companies in some states will see Canadian patients on a cash basis). You provide a US billing address (often a friend or family member in the US). You pay out of pocket if you have no US insurance, or you pay your US insurance copay if you happen to have US coverage. You receive an activation code that you can use from any geography. Some patients complete this. Most do not, because between the US physician fee, the prescription fee, the lack of insurance coverage, and the logistical complexity, the total cost and effort overshoots the simpler alternatives available in Canada directly.

Coverage even within the US is messy. US insurance coverage of prescription digital therapeutics like Regulora varies wildly even within the US market. Some commercial plans cover it, many do not. Medicare coverage of digital therapeutics has been an ongoing policy debate. Some patients in the US pay $0 out of pocket because their plan covers it cleanly, others pay $200 to $700 out of pocket per 12-week course because their plan does not. A Canadian patient pursuing the workaround should expect the unfavorable end of that range, because they will almost certainly be paying out of pocket without insurance pickup.

Why this matters. A Canadian IBS-D patient who has heard about Regulora through a podcast, a Reddit thread, or a US-based gastroenterologist often arrives at our consultation thinking it is just a matter of downloading the app. It is not. The realistic decision is between three actually-accessible Canadian options: Nerva at $199/year (same gut-directed hypnotherapy lineage, no prescription needed, available tonight), a Canadian gut-directed hypnotherapist at $220 to $350 per session, or a psychologist trained in gut-directed CBT covered by extended health benefits. Regulora belongs in a fourth bucket labeled 'theoretical option if you have US infrastructure'.

What does Regulora cost (when you can get it)?

Regulora's published pricing in the US is structured around the prescription pathway and insurance coverage, not a flat consumer price. Here is what Canadian patients should expect if they pursue the cross-border workaround, and how it compares to the Canadian-accessible alternatives.

Regulora US-side pricing. Manufacturer suggested out-of-pocket pricing for a 12-week course has historically sat in the $200 to $700 USD range depending on the period, the prescriber, and the distribution channel. Many US patients pay less than this because commercial insurance covers part or all of the cost. The exact number a Canadian would pay out-of-pocket varies, but planning for $400 to $700 USD for the digital therapeutic itself plus $100 to $300 USD for a US prescriber consultation is reasonable. That puts total cost in the $500 to $1,000 USD range, roughly $700 to $1,400 CAD at 2026 exchange rates, before any additional friction costs.

Nerva (Canadian-accessible alternative). $199 CAD per year. 6-week protocol, same gut-directed hypnotherapy lineage. No prescription, no friction. Available on the Canadian App Store tonight. For a first-time IBS-D patient who has never tried gut-directed hypnotherapy at all, this is the obvious starting point regardless of what Regulora costs in the US.

Mahana (limited Canadian access). Mahana IBS is another prescription digital therapeutic that is similarly US-centric in 2026. Cross-border access is similarly difficult. Roughly $90 USD per month when accessed.

Generic Canadian hypnotherapist (non-ARCH, non-specialized). Median $232 CAD per session from my 2026 study of 378 Canadian directories. A 6-session program runs $900 to $1,800. Quality varies because hypnotherapy is not a regulated profession in any Canadian province.

Psychologist using gut-directed CBT or hypnosis. $200 to $260 per session typical Canadian range, often largely reimbursed under extended health benefit plans because psychologists are a regulated profession. Often the most cost-effective clinician option for Canadians who have psychology coverage.

ARCH-credentialed gut-specialized clinician (e.g. Calgary Gut Hypnotherapy). $220 to $350 per session depending on complexity. 3-session commitment $660 to $1,050. Full 6 to 8 session protocol $1,320 to $2,800. ARCH (Association of Registered Clinical Hypnotherapists of Canada) is Canada's most stringent voluntary professional body for clinical hypnotherapy. Membership requires documented training hours, supervised practice, and adherence to a code of ethics.

Apples-to-apples for an IBS-D patient. If you can finish a 12-week self-guided protocol with no clinician involvement, Nerva at $199 CAD is the cheapest evidence-based option in Canada, and Regulora via cross-border workaround at $700 to $1,400 CAD is the same active ingredient at 4x to 7x the cost. If you have stalled on apps before, the comparison is no longer Regulora versus Nerva, it is digital therapeutic (either) versus clinician-delivered protocol, and a Canadian clinician at $220 to $350 per session is both more accessible and more accountable than a US-side digital therapeutic you have to construct cross-border access for.

What are the realistic alternatives for Canadian patients?

Most Canadian IBS-D patients researching Regulora end up choosing one of four actually-accessible alternatives. Here is the honest decision tree.

Start with Nerva ($199/year) if: You have never tried gut-directed hypnotherapy at all. Your IBS-D is mild to moderate. You are self-directed and confident you will complete a 6-week daily program. You want to test whether your nervous system responds to gut-directed hypnotherapy before spending real money. Nerva uses the same family of protocols as Regulora, has Peters 2016 RCT evidence behind the underlying approach, and is available in Canada tonight at one-quarter the cost of a Regulora cross-border attempt. For a large fraction of Canadians who arrive asking about Regulora, this is the right answer.

Try Mahana IBS if: You specifically want a prescription DTx structure and you happen to have US-side access that makes the cross-border pathway less painful for Mahana than Regulora. In practice this rarely changes the analysis, because the Canadian access friction is similar.

See a psychologist who does gut-directed CBT or hypnosis if: You have psychology coverage on your extended health benefits ($200 to $260 per session, often largely reimbursed). You have significant overlapping anxiety, depression, or trauma alongside the IBS-D. You want the work to be coverable through a regulated profession. The catch is finding a psychologist with actual gut-directed training, ask the question directly.

Book with an ARCH-credentialed gut-specialized clinician (CGT or similar practices) if: You have already tried an app and stalled or did not respond. Your IBS-D is moderate to severe, or there is overlap with SIBO, post-infectious IBS, functional dyspepsia, or IBD in remission. You want a clinician who will adjust the protocol session to session, follow up when you miss a week, and coordinate with your GP or gastroenterologist when the situation calls for it. You have the budget for $660 to $1,050 over a 3-session commitment, $1,320 to $2,800 for the full protocol.

Pursue Regulora cross-border only if: You already have US-side infrastructure (US billing address, US-licensed physician relationship, US insurance), you specifically want the 12-week prescription DTx structure over the alternatives, and you have IBS-D specifically (not IBS-C or IBS-M, which Regulora is not indicated for). This describes a small minority of Canadian patients.

Do something else entirely if: Your symptoms are red-flag (unexplained weight loss, blood in stool, anemia, new symptoms after age 50). See a gastroenterologist first. Gut-directed hypnotherapy in any form (app or clinician, US or Canadian) is for functional gut disorders, not for missed structural diagnoses.

What is not in this decision tree: 'Always pursue Regulora because FDA clearance'. The FDA clearance is a real differentiator inside the US market. It does not survive translation to a Canadian patient's actual access reality.

If you want gut-directed hypnotherapy delivered in Canada, where I fit (with conflict)

I have spent five sections being honest about Regulora's strengths and about the Canadian alternatives that are not me. Here is the part where I make the case for my own practice, with the conflict openly declared. Read accordingly.

What CGT is. A virtual-first clinical hypnotherapy practice specializing in gut-directed protocols for IBS (all subtypes including IBS-D), SIBO, functional dyspepsia, and gut-brain-axis conditions. I am ARCH-credentialed (Association of Registered Clinical Hypnotherapists of Canada, Canada's most stringent voluntary professional body for clinical hypnotherapy). Sessions are $220 to $350 depending on complexity, with a 3-session commitment ($660 to $1,050). Available virtually across Canada or in person in Calgary. I cap intake at 10 new clients per month so every client gets full focus.

Where CGT wins compared to Regulora for a Canadian IBS-D patient. Access, because I am in Canada and Regulora effectively is not. Personalization, because I adjust the protocol session to session based on what you reported the previous week, while Regulora delivers a fixed 12-week structure. Accountability, because I follow up when you miss a week and that is part of what you are paying for. Coordination, because I can call your Canadian GP or gastroenterologist, write a letter to your dietitian, talk to your benefits provider, in ways a US-side digital therapeutic cannot. Subtype flexibility, because I work across IBS-C, IBS-D, IBS-M, and overlap conditions, while Regulora is indicated specifically for IBS-D.

Where Regulora wins compared to CGT for the right patient. Regulatory validation, because FDA clearance is a real bar that no Canadian-delivered hypnotherapy holds. Cost (if you have US insurance pickup), because a US patient with covered DTx benefits may pay $0 to $200 out of pocket, which is cheaper than my 3-session commitment. Structure, because the 12-week prescription protocol is more standardized than a custom clinician-led plan. None of these wins actually translate for a Canadian patient without US infrastructure, which is the central problem.

Where CGT loses to Nerva. Cost. Nerva at $199/year is objectively cheaper than my 3-session commitment. For a first-time mild IBS-D patient who has never tried gut-directed hypnotherapy, Nerva is the honest starting recommendation and I will say so on the consultation call. I want to be the next step after Nerva for the patients who stall, not the first step for patients who have not even tried the app yet.

Insurance honest section. Hypnotherapy isn't directly covered by Canadian provincial health plans or most extended health benefit plans. Hypnotherapy isn't a regulated profession in Alberta. Some clients get reimbursement through their employer's Wellness Spending Account (WSA) under categories like 'stress management' or 'mental wellness'. WSAs are different from Health Spending Accounts (HSAs), which follow strict CRA medical-expense rules that exclude practitioners who aren't on a provincial regulated list. Always check with your specific plan whether RCH services qualify.

Bottom line on positioning. If you are an IBS-D patient in Canada who heard about Regulora and was hoping it was your answer, the realistic path is Nerva first, then an ARCH-credentialed gut-directed hypnotherapist if Nerva does not finish the job. Regulora is impressive on paper, mostly inaccessible in practice. The active ingredient is available here. The validated US delivery mechanism is not.